Gearing up to Further Propel Research at Rutgers Cancer Institute of New Jersey

Supporters of 'Century for the Cure' bike ride look to add to $2.25M raised since inception
July 13, 2018

Century for the CureNew Brunswick, N.J. – Aiming to add to the $2.25 million raised over the past 13 years, organizers of the annual Century for the Cure bike ride that supports research at Rutgers Cancer Institute of New Jersey are gearing up for another successful event. Registration for this year’s September 30 event, which features route options of 100, 62, 40 and 25 miles, is open at  

The ride is the result of Warren Township resident Scott Glickman’s desire to ‘give back’ to Rutgers Cancer Institute where he was treated for stage 4 non-Hodgkin lymphoma some two decades ago. Fewer than a dozen riders that first year grew into hundreds – riders, volunteers and supporters.  

“To see Century for the Cure grow through the years has been heartwarming – and knowing that this event translates into a source of funds that fuels groundbreaking research at Rutgers Cancer Institute and brings us closer to new anti-cancer therapies is amazing. My wife Aileen and I are grateful to all who support the ride each year, as it really does make an impact in the fight against cancer,” notes Glickman.

The ride supports cutting-edge clinical trials led by Glickman’s oncologist Roger Strair, MD, PhD, chief of blood disorders at Rutgers Cancer Institute. “Scott and Aileen’s continued commitment to Century for the Cure has helped us better understand what drives cancers like leukemia and lymphoma.  As a result, we have been able to translate that information into novel therapies which are administered through clinical trials – treatments that may not otherwise have been available to our patients. Our team is thankful for the Glickman family’s dedication to this event year after year,” says Dr. Strair, who is also a professor of medicine at Rutgers Robert Wood Johnson Medical School.  Funds from the ride also have supported grants for scientific investigators at Rutgers Cancer Institute to further explore varied blood cancers.

Along with multiple route options, there are also options to register as a ‘virtual’ rider or volunteer.  Learn how you can participate at the September 30 event at

About Rutgers Cancer Institute of New Jersey
Rutgers Cancer Institute, along with its partner RWJBarnabas Health, offers the most advanced cancer treatment options including clinical trials and novel therapeutics such as precision medicine and immunotherapy – many of which are not available at other facilities across the state.  Patients have access to these cutting-edge therapies throughout the state at Rutgers Cancer Institute of New Jersey in New Brunswick, Rutgers Cancer Institute of New Jersey at University Hospital in Newark, as well as at RWJBarnabas Health. 

Along with world-class treatment, which is often fueled by on-site research conducted in Rutgers Cancer Institute laboratories, patients and their families also can seek cancer preventative services and education resources throughout the Rutgers Cancer Institute and RWJBarnabas Health footprint statewide. To make a tax-deductible gift to support the Cancer Institute of New Jersey, call 848-932-8013 or visit Follow us on Facebook at

For journalists – contact:

Michele Fisher
Media Relations Specialist

For patient appointments/inquiries call 732-235-8515


image that says give now and support cancer research with link to giving page





Logo for ScreenNJ program and link to website





Robert Wood Johnson Barnabas Health logo with link to Partners page






Big Ten Cancer Research Consortium





Rutgers Health